April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
Bold steps toward a cure: Clinical trials at City of Hope
May 3, 2019 | Abe Rosenberg
City of Hope’s clinical trials program is special because it was built with the same core values as the institution itself: an emphasis on leading-edge medicine, compassionate care, rapid bench-to-bedside research and always putting the patient first.
Colorectal tumor biomarker may predict immunotherapy effectiveness
May 2, 2019 | Zen Vuong
The takeaway of foundational research by a City of Hope physician-scientist and his colleagues is that patients with metastatic colorectal cancer and a high tumor mutation score should consider immunotherapy as initial treatment.
John Rossi, Ph.D., receives highest honor from American Society of Gene and Cell Therapy
April 29, 2019 | Michael Easterling
John Rossi, Ph.D., the Lidow Family Research Chair and professor of the Department of Molecular and Cellular Biology, is the recipient of the 2019 Outstanding Achievement Award presented by the American Society of Gene and Cell Therapy.
International diabetes experts converge for Levine-Riggs symposium
April 23, 2019 | Michael Easterling
More than 250 physicians and scientists from around the world attended the 2019 City of Hope Levine-Riggs Diabetes Research Symposium, held April 10 to 13 at The Westin Hotel in Pasadena, California.
Exercise Lowers Heart Disease Risk in Breast Cancer Patients
April 23, 2019 | Letisia Marquez
After taking part in a 16-week exercise intervention, women who had early-stage breast cancer, and who were also inactive and overweight or obese, had a lower risk of developing cardiovascular disease, according to a new study in JAMA Oncology.
TGen IDs gene associated with most common liver cancer
April 19, 2019 | City of Hope
AKR1B10 could help provide early detection of hepatocellular carcinoma, and play a role in monitoring and treating this growing cause of cancer death.
Combined immunotherapy could tackle advanced cancers
April 15, 2019 | Zen Vuong
City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.